GR

Gopal Reddy Annareddy

Active Director Director DIN 07306495
DIN 07306495 First appointment Oct 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Oct 2015
Shareholding value •••• Premium profile

About Gopal Reddy Annareddy

Data last updated:

Gopal Reddy Annareddy is a Director at Hetero Drugs Limited (since 2023) and Director at Honour Lab Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5,807 Cr; the largest is Hetero Drugs Limited at ₹3,324 Cr (FY 2025). Earlier, Gopal Reddy Annareddy was a Director at Hetero Labs Limited (2015–2023).

DIN 07306495
Primary Designation Director
Industry Pharma
First Appointment 08 Oct 2015
Oldest Company Age 33 yrs
Largest company Hetero Drugs Limited · ₹3,324 Cr (FY 2025)
Combined revenue ₹5,807 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hetero Drugs Limited U24230TG1993PLC015582
Director21 Dec 20231993₹3,324 Cr (FY 2025)Active
Honour Lab Limited U24233TG2011PLC077561
Director18 Dec 20232011₹2,483 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hetero Labs Limited U24110TG1989PLC009723
Director08 Oct 20151989₹16,537 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Gopal Reddy Annareddy

NameDINCompanyDesignation
Adi Sesha Giri Jagarapu08774486Hetero Drugs Limited , Honour Lab LimitedDirector
Bandi Vamsikrishna01014619Hetero Drugs LimitedDirector
Kalavathi Bandi00194597Hetero Drugs LimitedDirector
Kaza Sai Venkata Sharath KrishnaHetero Drugs LimitedCompany Secretary
Parthasaradhi Reddy Bandi00015899Hetero Drugs LimitedDirector
Sambi Reddy Jonnala00211459Hetero Drugs LimitedWhole-Time Director
Venkatanarasa Reddy Attunuri00023432Hetero Drugs LimitedDirector
Kesireddy Subhas Chander Reddy07254929Honour Lab LimitedWhole-Time Director
Krishnaveni Kura07033330Honour Lab LimitedDirector
Rathnakar Reddy Kura00211510Honour Lab LimitedManaging Director
Srinivas VengalaHonour Lab LimitedCompany Secretary

Directorship timeline

Open interactive timeline →
Honour Lab Limited
Hetero Drugs Limited
Hetero Labs Limited
Premium access

Shareholding and investment profile for Gopal Reddy Annareddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gopal Reddy Annareddy

Gopal Reddy Annareddy currently holds 2 directorships: Hetero Drugs Limited (Director, since 21 Dec 2023, revenue ₹3,324 Cr (FY 2025)); Honour Lab Limited (Director, since 18 Dec 2023, revenue ₹2,483 Cr (FY 2025)).

Gopal Reddy Annareddy was first appointed on 08 Oct 2015 as Director at Hetero Labs Limited. The most recent appointment on record is 21 Dec 2023 at Hetero Drugs Limited.

The 2 current companies of Gopal Reddy Annareddy that report revenue have a combined latest revenue of ₹5,807 Cr: Hetero Drugs Limited ₹3,324 Cr (FY 2025); Honour Lab Limited ₹2,483 Cr (FY 2025).

Gopal Reddy Annareddy held 1 earlier board appointment: Hetero Labs Limited (Director, 08 Oct 2015 to 07 Oct 2023).

The current boards of Gopal Reddy Annareddy's companies include Adi Sesha Giri Jagarapu (Hetero Drugs Limited), Bandi Vamsikrishna (Hetero Drugs Limited), Kalavathi Bandi (Hetero Drugs Limited), Kaza Sai Venkata Sharath Krishna (Hetero Drugs Limited), Parthasaradhi Reddy Bandi (Hetero Drugs Limited), Sambi Reddy Jonnala (Hetero Drugs Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available